tandospirone has been researched along with Allodynia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, T; Kuraishi, Y; Sakamoto, A | 1 |
1 other study(ies) available for tandospirone and Allodynia
| Article | Year |
|---|---|
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice.
Topics: Animals; Cell Movement; Hyperalgesia; Isoindoles; Male; Mast Cells; Mice; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyridines; Pyrimidines; Serotonin 5-HT1 Receptor Agonists; Skin | 2016 |